Pharmaceutical Preparations
"Pharmaceutical Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
| Descriptor ID |
D004364
|
| MeSH Number(s) |
D26
|
| Concept/Terms |
Pharmaceutical Preparations- Pharmaceutical Preparations
- Pharmaceutic Preparations
- Preparations, Pharmaceutic
- Preparations, Pharmaceutical
- Drugs
- Pharmaceutical Products
- Products, Pharmaceutical
|
Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Preparations".
Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Preparations".
This graph shows the total number of publications written about "Pharmaceutical Preparations" by people in this website by year, and whether "Pharmaceutical Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2004 | 1 | 2 | 3 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 19 | 14 | 33 |
| 2018 | 17 | 14 | 31 |
| 2019 | 10 | 7 | 17 |
| 2020 | 33 | 7 | 40 |
| 2021 | 46 | 0 | 46 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmaceutical Preparations" by people in Profiles.
-
Warp Speed for Coronavirus Disease 2019 (COVID-19) Drugs and Vaccines--Time to Reconsider How We Use the Term "Children". Clin Infect Dis. 2022 01 07; 74(1):168-169.
-
A pharmacist-managed virtual consult service for patients with rheumatologic conditions requiring specialty or infused medications. Am J Health Syst Pharm. 2022 Jan 01; 79(1):e41-e49.
-
Understanding Drug Development: A Primer on the Food and Drug Administration. J Pediatric Infect Dis Soc. 2021 Nov 11; 10(10):977-981.
-
Outpatient Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection to Prevent Coronavirus Disease 2019 Progression. Clin Infect Dis. 2021 11 02; 73(9):1717-1721.
-
Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit. Arq Neuropsiquiatr. 2021 Oct; 79(10):924-928.
-
Simulating drug concentrations in PDMS microfluidic organ chips. Lab Chip. 2021 09 14; 21(18):3509-3519.
-
Re: "Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients," by Kumar et al. Assay Drug Dev Technol. 2021 10; 19(7):408-409.
-
Health emergencies and interoceptive sensibility modulate the perception of non-evidence-based drug use: Findings from the COVID-19 outbreak. PLoS One. 2021; 16(8):e0256806.
-
Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study. Adv Ther. 2021 10; 38(10):5165-5177.
-
Heterogeneous graph attention networks for drug virus association prediction. Methods. 2022 02; 198:11-18.